Searched for
PRESCRIPTION DRUG SETTLEMENT
Kroger savings club settlement: You may be eligible for payment in $17 million class-action settlement over pricing claims; check eligibility, deadline, payout and moreKroger customers may receive a share of a proposed $17 million class-action settlement. This settlement addresses allegations of overchargi...- Quote of the day by Princess Diana: 'Let’s not wait to be prompted. Let us go out today, tomorrow and the days that follow and let us...' Life lessons from inspirational quote on compassion, suffering, proactive kindness, consistency and humanityQuote of the day by Princess Diana highlights the need to show compassion through action. Her December 12, 1995 speech called on people to ...
- Will you have to pay Medical Surcharge next year? How much is IRMAA, and how to avoid or reduce it?The Social Security Administration (SSA) bases Medicare premiums on tax returns from two years earlier, meaning your 2024 income will deter...
- Sun Pharma shares in focus following US launch of LEQSELVITM, settlement with Incyte CorporationSun Pharma shares: In a regulatory filing on Monday, Sun Pharma announced that it has reached a settlement and licensing agreement with Inc...
- Consulting firm McKinsey to pay $650 million to resolve US criminal opioid probeMcKinsey & Co. agreed to a $650 million settlement with the DOJ, resolving a criminal investigation into their role in advising Purdue Phar...
- eBay to pay $59 million to settle US charges over illegal pill-making machinesThe settlement arose from eBay's alleged inadequate monitoring since October 2015 of thousands of pill presses and encapsulating machines s...
- Supreme Court weighs landmark Purdue Pharma settlement impacting opioid crisisThe Supreme Court weighs a pivotal Purdue Pharma settlement shielding the Sackler family from opioid crisis lawsuits. The $6 billion agreem...
- McKinsey to pay $230 mn in latest US opioid settlementConsulting firm McKinsey & Co has agreed to pay $230 million in its latest settlement to resolve lawsuits alleging it fueled a US opioid ep...
- US pharmacy chains to pay $10 bn to settle opioid casesUS pharmacy chains CVS Health and Walgreens said Wednesday they had reached preliminary agreements to together pay more than $10 billion to...
- Lupin's foray into diagnostics appears a calculated riskThe under-performing pharma company's foray into a competitive services business like diagnostics may seem counter-intuitive, as Lupin has ...
- Dispute settlement gives this stock an edge over peers in pharma packKunal Dhamesha of Emkay Global raised his price target for the stock to Rs 1,000 and sees potential gain of Rs 45 per share from the settle...
- Novartis pays $678 million to resolve suit over sham doctor outingsThe settlement of the lawsuit was announced by Acting Manhattan U.S. Attorney Audrey Strauss, who said the company splurged on "speaking fe...
- E-commerce needs clarity on sale of prescription medicinesIts mandatory for e-pharmacies to register with Central Licencing Authority and they are restricted from selling narcotics, tranquilisers a...
- J&J ordered to pay USD 572 million for opioid addiction crisisJ&J's shares rose about two percent to USD 130 in after-market trade following the decision.
- Dr Reddy's Labs gains as drug maker settles 6-year old case in USThe pharma company has settled the matter for $5 million.
- Dr Reddy's Laboratories will infringe on Lunesta's patent: US court of appealThe United States Court of Appeals for the Federal Circuit has ruled that Dr Reddy's Laboratories Ltd will (rpt will) infringe on the paten...
- Sun Pharma to pay Rs 2,517 crore to settle patent suitDuring the June quarter, Sun Pharma settled the ongoing litigation pending in the US District Court, District of New Jersey regarding its s...
- Start-up dWise provides online record of patients & alerts against prescribing ‘wrong’ drugBangalore-based start-up dWise is ready to inject tech into health care so that a doctor accesses the entire record of a patient online.
- Ranbaxy Laboratories close to claiming 50% share of atorvastatin market in 6-month exclusivity periodA Ranbaxy spokesman declined comment but people familiar with Ranbaxy marketing plans said the company's share would cross 50% in about a m...
- Pfizer marketing may hit Ranbaxy’s profit from low-cost lipitor versionLate last year, Pfizer started offering ‘co-pay’ programmes which lowered out of pocket payment by insured patients to $4 a month for a Lip...
Load More
